GlassScriptPhysician profile
David J Jacofsky
NPI 1922040179
$11,305,174.80
in general payments reported to CMS, 2019-2025
9 companies · $1.9M in 2025
The $1.9M reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.4M · 2020: $1.3M · 2021: $1.4M · 2022: $1.9M · 2023: $1.6M · 2024: $1.7M · 2025: $1.9M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.2M · Travel and Lodging: $47K · Consulting Fee: $11K · Food and Beverage: $5,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,154,135.87 |
| Travel and Lodging | $47,348.59 |
| Consulting Fee | $10,890.00 |
| Food and Beverage | $5,687.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,800,789.44 | 2019-2025 | Accolade, Mako, Trident |
| Depuy Synthes Sales INC. | $503,460.74 | 2022 | |
| Smith+Nephew, INC. | $609.51 | 2021-2025 | Real Intelligence, Ri Hip Navigation, Journey |
| Surgalign Spine Technologies, INC. | $90.06 | 2021 | |
| Crossroads Extremity Systems, LLC | $83.92 | 2019 | |
| Biocomposites INC | $49.69 | 2019 | |
| Boston Scientific Corporation | $38.57 | 2021 | |
| Onkos Surgical, INC. | $37.31 | 2019 | |
| My01 INC. | $15.56 | 2025 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$487,500.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jacofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.